Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Dexmedetomidine increases the cocaine seizure threshold in rats.

Whittington RA, Virag L, Vulliemoz Y, Cooper TB, Morishima HO.

Anesthesiology. 2002 Sep;97(3):693-700.

PMID:
12218537
2.

Dexmedetomidine decreases extracellular dopamine concentrations in the rat nucleus accumbens.

Whittington RA, Virag L, Morishima HO, Vulliemoz Y.

Brain Res. 2001 Nov 16;919(1):132-8.

PMID:
11689170
3.

The nitric oxide-cGMP system of the locus coeruleus and the hypnotic action of alpha-2 adrenergic agonists.

Vulliemoz Y, Whittington RA, Virag L.

Brain Res. 1999 Dec 4;849(1-2):169-74.

PMID:
10592299
5.

Interaction of the alpha-2 adrenergic- and opioid receptor with the cGMP system in the mouse cerebellum.

Vulliemoz Y, Virag L, Whittington RA.

Brain Res. 1998 Nov 30;813(1):26-31.

PMID:
9824660
6.

Intra-arterial nitrovasodilators do not increase cerebral blood flow in angiographically normal territories of arteriovenous malformation patients.

Joshi S, Young WL, Pile-Spellman J, Fogarty-Mack P, Sciacca RR, Hacein-Bey L, Duong H, Vulliemoz Y, Ostapkovich N, Jackson T.

Stroke. 1997 Jun;28(6):1115-22.

7.

Plasma neuropeptide Y and catecholamines in pediatric patients undergoing cardiac operations.

Sun LS, Du F, Schechter WS, Quaegebeur JM, Vulliemoz Y.

J Thorac Cardiovasc Surg. 1997 Feb;113(2):278-84.

8.

Alpha-2 adrenoceptor agonists decrease cyclic guanosine 3',5'-monophosphate in the mouse brain.

Vulliemoz Y, Shen H, Virag L.

Anesthesiology. 1996 Sep;85(3):544-50.

PMID:
8853084
9.

Superselective intraarterial papaverine administration: effect on regional cerebral blood flow in patients with arteriovenous malformations.

Fogarty-Mack P, Pile-Spellman J, Hacein-Bey L, Ostapkovich N, Joshi S, Vulliemoz Y, Young WL.

J Neurosurg. 1996 Sep;85(3):395-402.

PMID:
8751623
10.

Muscarinic receptor heterogeneity in neonatal rat ventricular myocytes in culture.

Sun LS, Huber F, Robinson RB, Bilezikian JP, Steinberg SF, Vulliemoz Y.

J Cardiovasc Pharmacol. 1996 Apr;27(4):455-61.

PMID:
8847859
11.

An excitatory muscarinic response in neonatal rat ventricular myocytes and its modulation by sympathetic innervation.

Sun LS, Vulliemoz Y, Huber F, Bilezikian JP, Robinson RB.

J Mol Cell Cardiol. 1994 Jun;26(6):779-87.

PMID:
7522276
12.
13.
15.

Volatile anesthetics and second messengers in cardiac tissue.

Vulliemoz Y.

Adv Exp Med Biol. 1991;301:169-80. No abstract available.

PMID:
1662461
16.
17.

Halothane interaction with guanine nucleotide binding proteins in mouse heart.

Vulliemoz Y, Verosky M.

Anesthesiology. 1988 Dec;69(6):876-80.

PMID:
2848425
18.

The inotropic effects of amrinone and milrinone on neonatal and young canine cardiac muscle.

Binah O, Sodowick B, Vulliemoz Y, Danilo P Jr, Rosen M.

Circulation. 1986 Mar;73(3 Pt 2):III46-51.

PMID:
3002663
19.

Effect of halothane on myocardial cyclic AMP and cyclic GMP content of mice.

Vulliemoz Y, Verosky M, Triner L.

J Pharmacol Exp Ther. 1986 Jan;236(1):181-6.

PMID:
2867213
20.

Deuterated halothane--anesthetic potency, anticonvulsant activity, and effect on cerebellar cyclic guanosine 3',5'-monophosphate.

Vulliemoz Y, Triner L, Verosky M, Hamm MW, Krishna G.

Anesth Analg. 1984 May;63(5):495-8.

PMID:
6324614
21.

Developmental changes in adenylate cyclase activity in canine myocardium.

Vulliemoz Y, Verosky M, Rosen MR, Triner L.

Dev Pharmacol Ther. 1984;7(6):409-21.

PMID:
6097424
22.

Effect of enflurane on cerebellar cGMP and on motor activity in the mouse.

Vulliemoz Y, Verosky M, Alpert M, Triner L.

Br J Anaesth. 1983 Jan;55(1):79-84.

23.

Senescence-related changes in the responsiveness to ouabain of canine Purkinje fibers.

Hewett K, Vulliemoz Y, Rosen MR.

J Pharmacol Exp Ther. 1982 Oct;223(1):153-6.

PMID:
7120115
24.

Effect of a prostaglandin antagonist, N-0164, on cAMP generation and hydrolysis in the rat uterus.

Vulliemoz Y, Verosky M, Triner L.

Biochem Pharmacol. 1981 Jul 15;30(14):1941-6. No abstract available.

PMID:
6268114
25.

Halothane effect on beta-adrenergic receptors in canine myocardium.

Bernstein KJ, Gangat Y, Verosky M, Vulliemoz Y, Triner L.

Anesth Analg. 1981 Jun;60(6):401-5.

PMID:
6263132
26.

Halothane effect on cGMP and control of motor activity in mouse cerebellum.

Triner L, Vulliemoz Y, Verosky M, Alpert M.

Anesthesiology. 1981 Mar;54(3):193-8.

PMID:
6258459
27.

Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.

Walter F, Vulliemoz Y, Verosky Y, Triner L.

Anesth Analg. 1980 Nov;59(11):856-61.

PMID:
6252800
28.

Halothane effect on cAMP generation and hydrolysis in rat brain.

Triner L, Vulliemoz Y, Woo SY, Verosky M.

Eur J Pharmacol. 1980 Aug 22;66(1):73-80.

PMID:
6250863
29.
30.

Dopamine-sensitive adenylate cyclase activity in the rat caudate nucleus during exposure to halothane and enflurane.

Woo SY, Verosky M, Vulliemoz Y, Triner L.

Anesthesiology. 1979 Jul;51(1):27-33. No abstract available.

PMID:
222172
31.

Action of halothane on myocardial adenylate cyclase of rat and cat.

Gangat Y, Vulliemoz Y, Verosky M, Danilo P, Bernstein K, Triner L.

Proc Soc Exp Biol Med. 1979 Feb;160(2):154-9. No abstract available.

PMID:
419139
32.
33.

The action of halothane on adenylate cyclase.

Triner L, Vulliemoz Y, Verosky M.

Mol Pharmacol. 1977 Sep;13(5):976-9. No abstract available.

PMID:
895727
34.

Adenylate cyclase and phosphodiesterase activity in rabbit ureter.

Weiss RM, Vulliemoz Y, Verosky M, Rosen MR, Triner L.

Invest Urol. 1977 Jul;15(1):15-8.

PMID:
194862
35.

Cyclic 3',5'-adenosine monophosphate and bronchial tone.

Triner L, Vulliemoz Y, Verosky M.

Eur J Pharmacol. 1977 Jan 7;41(1):37-46.

PMID:
188660
36.
37.

Ouabain-induced changes in electrophysiologic properties of neonatal, young and adult canine cardiac Purkinje Fibers.

Rosen MR, Hordof AJ, Hodess AB, Verosky M, Vulliemoz Y.

J Pharmacol Exp Ther. 1975 Jul;194(1):255-63.

PMID:
1151753
38.

Cyclic adenosine monophosphate and vascular reactivity in spontaneously hypertensive rats.

Triner L, Vulliemoz Y, Verosky M, Manger WM.

Biochem Pharmacol. 1975 Mar 15;24(6):743-5. No abstract available.

PMID:
164872
39.

Effects of halothane on the cyclic 3',5'-adenosine monophosphate (cyclic AMP) system in rat uterine muscle.

Yang JC, Triner L, Vulliemoz Y, Verosky M, Ngai SH.

Anesthesiology. 1973 Mar;38(3):244-59. No abstract available.

PMID:
4144581
40.

Adenyl cyclase-phosphodiesterase system in arterial smooth muscle.

Triner L, Vulliemoz Y, Verosky M, Habif DV, Nahas GG.

Life Sci I. 1972 Sep 1;11(17):817-24. No abstract available.

PMID:
4347988
41.

Acetylcholine and the cyclic AMP system in smooth muscle.

Triner L, Vulliemoz Y, Verosky M, Nahas GG.

Biochem Biophys Res Commun. 1972 Mar 10;46(5):1866-73. No abstract available.

PMID:
4335569
42.

Cyclic AMP and smooth muscle function.

Triner L, Nahas GG, Vulliemoz Y, Overweg NT, Verosky M, Habif DV, Ngai SH.

Ann N Y Acad Sci. 1971 Dec 30;185:458-76. No abstract available.

PMID:
4330512
43.

Activated lipolysis and pH changes.

Nahas GG, Poyart CF, Kleisbauer JP, Verosky M, Vulliemoz Y.

Ann N Y Acad Sci. 1971 Dec 30;185:137-51. No abstract available.

PMID:
4330488
44.

Cyclic phosphodiesterase activity and the action of papaverine.

Triner L, Vulliemoz Y, Schwartz I, Nahas GG.

Biochem Biophys Res Commun. 1970 Jul 13;40(1):64-9. No abstract available.

PMID:
4318586
45.

The effect of catecholamines on adenyl cyclase activity in rat uterus.

Triner L, Vulliemoz Y, Verosky M, Nahas GG.

Life Sci I. 1970 Jun 15;9(12):707-12. No abstract available.

PMID:
4319676
46.

Effects of ouabain on insulin secretion in the dog.

Triner L, Papayoanou J, Killian P, Vulliemoz Y, Castany R, Nahas GG.

Circ Res. 1969 Aug;25(2):119-29. No abstract available.

47.

Interaction of ouabain with drugs activating lipolysis in vitro.

Vulliemoz Y, Triner L, Nahas G.

Life Sci. 1968 Oct 15;7(20):1063-73. No abstract available.

PMID:
4305725
48.

[Interaction of ouabain and lipolytic drugs].

Vulliemoz Y, Triner L, Nahas G.

J Physiol (Paris). 1968;60 Suppl 2:569. French. No abstract available.

PMID:
4309575
49.

Regulation of activated lipolysis by albumin, glucose, and H+.

Poyart CF, Vulliemoz Y, Nahas GG.

Proc Soc Exp Biol Med. 1967 Jul;125(3):863-8. No abstract available.

PMID:
15938286

Supplemental Content

Loading ...
Support Center